Cresco Labs Inc.
CL
CNSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.50% | -0.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.50% | -0.29% | |||
| Cost of Revenue | -3.61% | -2.72% | |||
| Gross Profit | 0.56% | 2.20% | |||
| SG&A Expenses | 7.91% | -1.91% | |||
| Depreciation & Amortization | 9.89% | -4.30% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.02% | -2.49% | |||
| Operating Income | -12.87% | 10.97% | |||
| Income Before Tax | 127.65% | -356.72% | |||
| Income Tax Expenses | 85.74% | -43.13% | |||
| Earnings from Continuing Operations | 84.97% | -2,390.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 9.71% | -0.48% | |||
| Net Income | 80.60% | -946.25% | |||
| EBIT | -12.87% | 10.97% | |||
| EBITDA | -8.85% | 6.34% | |||
| EPS Basic | 80.76% | -936.18% | |||
| Normalized Basic EPS | 119.05% | -542.11% | |||
| EPS Diluted | 80.76% | -936.18% | |||
| Normalized Diluted EPS | 119.05% | -542.11% | |||
| Average Basic Shares Outstanding | 0.70% | 0.97% | |||
| Average Diluted Shares Outstanding | 0.70% | 0.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
